Polymorphisms in NOD2 have been associated with the risk of many cancers, including lymphoma, CRC, gastric cancer, breast cancer, ovarian cancer, lung cancer, and laryngeal cancer [9]. Here, NOD2 is linked to ovarian carcinoma.